• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新生儿重症监护病房中基因组检测技术的诊断和服务影响。

Diagnostic and service impact of genomic testing technologies in a neonatal intensive care unit.

机构信息

Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.

出版信息

J Paediatr Child Health. 2019 Nov;55(11):1309-1314. doi: 10.1111/jpc.14398. Epub 2019 Feb 12.

DOI:10.1111/jpc.14398
PMID:30756437
Abstract

AIM

To investigate the diagnostic and service impact of chromosomal microarray and whole exome sequencing (WES) in a neonatal intensive care unit (NICU).

METHODS

This was a retrospective medical record review of NICU patients referred for genetics consultation at three time points over a 9-year period at a single centre to determine referral indications, genetic consultation outcomes and time to diagnosis.

RESULTS

The number of NICU patients referred for genetics consultation increased from 44 in 2007 to 95 in 2015. The proportion of NICU patients suspected of having a genetic condition following clinical geneticist assessment remained stable, averaging 5.3% of all admissions. The proportion of patients receiving a confirmed diagnosis rose from 21% in 2007 to 53% in 2015, with a shift from primarily chromosomal abnormalities to a broad range of monogenic disorders, increasingly diagnosed by WES as a first-tier test. The average age at diagnosis in 2015 was 19 days (range 12-38 days) for chromosomal abnormalities and 138 days (range 10-309 days) for monogenic conditions.

CONCLUSIONS

The adoption of new genetic technologies at our centre has increased the proportion of patients receiving a confirmed genetic diagnosis. This study provides important benchmark data to measure further improvements as turn-around times for genomic testing decrease.

摘要

目的

探讨染色体微阵列和全外显子组测序(WES)在新生儿重症监护病房(NICU)中的诊断和服务影响。

方法

这是一项回顾性病历审查,对在一家中心的 9 年期间的三个时间点因遗传学咨询而被转介到新生儿重症监护病房的患者进行研究,以确定转介指征、遗传咨询结果和诊断时间。

结果

NICU 患者因遗传学咨询而被转介的数量从 2007 年的 44 例增加到 2015 年的 95 例。经过临床遗传学家评估后,疑似患有遗传疾病的 NICU 患者比例保持稳定,平均占所有入院患者的 5.3%。接受确诊诊断的患者比例从 2007 年的 21%上升到 2015 年的 53%,从主要的染色体异常到广泛的单基因疾病,越来越多地通过 WES 作为一线测试进行诊断。2015 年的平均诊断年龄为染色体异常的 19 天(范围为 12-38 天)和单基因疾病的 138 天(范围为 10-309 天)。

结论

我们中心采用新的遗传技术增加了接受确诊遗传诊断的患者比例。本研究提供了重要的基准数据,随着基因组测试的周转时间缩短,可进一步衡量改进情况。

相似文献

1
Diagnostic and service impact of genomic testing technologies in a neonatal intensive care unit.新生儿重症监护病房中基因组检测技术的诊断和服务影响。
J Paediatr Child Health. 2019 Nov;55(11):1309-1314. doi: 10.1111/jpc.14398. Epub 2019 Feb 12.
2
RAPIDOMICS: rapid genome-wide sequencing in a neonatal intensive care unit-successes and challenges.快速基因组测序在新生儿重症监护病房的应用:成功与挑战。
Eur J Pediatr. 2019 Aug;178(8):1207-1218. doi: 10.1007/s00431-019-03399-4. Epub 2019 Jun 7.
3
Intersociety policy statement on the use of whole-exome sequencing in the critically ill newborn infant.儿科学界关于在危重新生儿中使用全外显子组测序的政策声明。
Ital J Pediatr. 2017 Nov 3;43(1):100. doi: 10.1186/s13052-017-0418-0.
4
Medical costs of children admitted to the neonatal intensive care unit: The role and possible economic impact of WES in early diagnosis.新生儿重症监护病房患儿的医疗费用:WES 在早期诊断中的作用和可能的经济影响。
Eur J Med Genet. 2022 May;65(5):104467. doi: 10.1016/j.ejmg.2022.104467. Epub 2022 Mar 1.
5
Feasibility of Ultra-Rapid Exome Sequencing in Critically Ill Infants and Children With Suspected Monogenic Conditions in the Australian Public Health Care System.在澳大利亚公共医疗体系下,超快速外显子组测序在疑似单基因病的危重症婴儿和儿童中的可行性。
JAMA. 2020 Jun 23;323(24):2503-2511. doi: 10.1001/jama.2020.7671.
6
Whole-exome sequencing as the first-tier test for patients in neonatal intensive care unit: a Chinese single-center study.对新生儿重症监护病房患者进行全外显子组测序作为一线检测:一项中国单中心研究。
BMC Pediatr. 2024 May 22;24(1):351. doi: 10.1186/s12887-024-04820-0.
7
Use of medical exome sequencing for identification of underlying genetic defects in NICU: Experience in a cohort of 2303 neonates in China.应用外显子组测序鉴定新生儿重症监护病房中潜在的遗传缺陷:在中国 2303 例新生儿队列中的经验。
Clin Genet. 2022 Jan;101(1):101-109. doi: 10.1111/cge.14075. Epub 2021 Oct 25.
8
Making a Genetic Diagnosis in a Level IV Neonatal Intensive Care Unit Population: Who, When, How, and at What Cost?在四级新生儿重症监护病房人群中进行基因诊断:谁、何时、如何以及成本如何?
J Pediatr. 2019 Oct;213:211-217.e4. doi: 10.1016/j.jpeds.2019.05.054. Epub 2019 Jun 27.
9
Exome and Whole Genome Sequencing in the Neonatal Intensive Care Unit.新生儿重症监护病房中的外显子组和全基因组测序。
Clin Perinatol. 2022 Mar;49(1):167-179. doi: 10.1016/j.clp.2021.11.018. Epub 2022 Jan 21.
10
Detection and impact of genetic disease in a level IV neonatal intensive care unit.在四级新生儿重症监护病房中检测和评估遗传疾病。
J Perinatol. 2022 May;42(5):580-588. doi: 10.1038/s41372-022-01338-0. Epub 2022 Feb 18.

引用本文的文献

1
Benefits and barriers to broad implementation of genomic sequencing in the NICU.新生儿重症监护病房广泛开展基因组测序的益处与障碍。
Am J Hum Genet. 2025 Jun 5;112(6):1270-1285. doi: 10.1016/j.ajhg.2025.04.007. Epub 2025 May 13.
2
Perspectives of United States neonatologists on genetic testing practices.美国新生儿科医生对基因检测实践的看法。
Genet Med. 2022 Jun;24(6):1372-1377. doi: 10.1016/j.gim.2022.02.009. Epub 2022 Mar 15.
3
Rapid genomic testing for critically ill children: time to become standard of care?危重症儿童的快速基因组检测:是时候成为标准治疗了吗?
Eur J Hum Genet. 2022 Feb;30(2):142-149. doi: 10.1038/s41431-021-00990-y. Epub 2021 Nov 8.
4
Expanding the genotypes and phenotypes for 19 rare diseases by exome sequencing performed in pediatric intensive care unit.通过在儿科重症监护病房进行外显子组测序,扩展了 19 种罕见病的基因型和表型。
Hum Mutat. 2021 Nov;42(11):1443-1460. doi: 10.1002/humu.24266. Epub 2021 Aug 15.
5
Measurement of genetic diseases as a cause of mortality in infants receiving whole genome sequencing.将全基因组测序用于测量作为婴儿死亡原因的遗传疾病。
NPJ Genom Med. 2020 Nov 2;5:49. doi: 10.1038/s41525-020-00155-8. eCollection 2020.
6
The influence of social determinants of health on the genetic diagnostic odyssey: who remains undiagnosed, why, and to what effect?社会健康决定因素对基因诊断探索之旅的影响:谁未被诊断,原因是什么,以及有何影响?
Pediatr Res. 2021 Jan;89(2):295-300. doi: 10.1038/s41390-020-01151-5. Epub 2020 Sep 15.